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Abstract
Failure of bone under monotonic and cyclic loading is related to the bone mineral density, the quality
of the bone matrix and the evolution of microcracks. The theory of linear elastic fracture mechanics
has commonly been applied to describe fracture in bone. Evidence is presented that bone failure can
be described through a non-linear theory of fracture. Thereby, deterministic size effects are
introduced. Concepts of a non-linear theory are applied to discern how the interaction among bone
matrix constituents (collagen and mineral), microcrack characteristics, and trabecular architecture
can create distinctively differences in the fracture resistance at the bone tissue level. The nonlinear
model is applied to interpret pre-clinical data concerning the effects of anti-osteoporotic agents on
bone properties. The results show that bisphosphonate (BP) treatments that suppress bone remodeling
will change trabecular bone in ways such that the size of the failure process zone relative to the
trabecular thickness is reduced. Selective estrogen receptor modulators (SERMs) that suppress bone
remodeling will change trabecular bone in ways such that the size of the failure process zone relative
to the trabecular thickness is increased. The consequences of these changes are reflected in bone
mechanical response and predictions are consistent with experimental observations in the animal
model which show that BP treatment is associated with more brittle fracture and microcracks without
altering the average length of the cracks, whereas SERM treatments lead to a more ductile fracture
and mainly increase crack length with a smaller increase in microcrack density. The model suggests
that BPs may be more effective in cases in which bone mass is very low, whereas SERMS may be
more effective when milder osteoporotic symptoms are present.
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1. Introduction
Recent work in an animal model has documented that two common classes of osteoporosis
treatments [bisphosphonates (BPs) and Selective Estrogen Receptor Modulators (SERMs)],
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both of which suppress bone remodeling rate, alter the mechanical properties of trabecular
bone and lead to distinctly different microdamage accumulation (Allen et al. 2006). However,
they do so by different mechanisms.
BPs (alendronate and risedronate) increase bone mineral density and bone volume (with
statistical significance), in part by increasing trabecular thickness (without statistical
significance). BPs also change the collagen cross-linking state of the bone tissue (Allen et al.,
2008). Such treatment was found to increase ultimate load of trabecular bone (without statistical
significance) as well as the stiffness (with statistical significance). BP treatments were found
to increase the microcrack density without altering the average length of the cracks.
On the other hand, SERMs (raloxifene) alter bone mechanical properties without significant
changes to either bone mineral density or bone volume (Allen et al., 2007), but still increase
trabecular thickness (without statistical significance). SERMs change the collagen cross-
linking state little. Nevertheless, an increase ultimate load of trabecular bone (but without
statistical significance) as well as stiffness (with statistical significance) were found.
Interestingly, SERM treatment mainly increases the length of microcracks, with a smaller
increase in the crack density.
Changes in turnover do not explain that changes in microdamage accumulation and crack
length that are observed experimentally. Experimental results show that BPs and SERMs
suppress remodeling to different degrees, but at clinical doses the microcrack density is about
the same. Moreover, at these doses, the length of microcracks is significantly longer with
SERMs than with BPs, yet one might expect, because BPs suppress remodeling to a greater
degree, that cracks would not be repaired as quickly and microcracks might be longer. The
mechanism underlying these differences is unclear, yet is important to understand with respect
to the mechanism by which these agents reduce fracture risk. The purpose of this study was to
provide a plausible mathematical explanation for these results.
Following the theories of cellular solids, when a specimen of trabecular bone is subjected to
compressive loading individual trabeculae are subjected to bending, and bending deflection
then relates to the deformation under the applied compressive load. There is experimental
evidence that failure of trabecular bone under compressive loading is related to the formation
of zones of localized deformation. Zones of local deformation appear as whitening zones under
low magnification imaging, but under high magnification are shown to be delamination type
defects aligned with the axis of anisotropy of the bone tissue. The delaminations are fully or
partially bridged by collagen fibrils. In addition, crack bridges formed by uncracked ligaments
can also be seen. The presence of such mechanisms has been identified to contribute
significantly to the resistance to failure both in trabecular (Thurner et al, 2009) and cortical
bone (Nalla et al., 2004). The effectiveness of either mechanism is ultimately dependent on
the properties of the mineralized collagen fibrils as they are the building blocks of the tissue.
The presence of such fracture processes motivates the use of non-linear fracture models to
describe processes underlying failure of individual trabeculae as constituents of cancellous
bone. Non-linear fracture mechanics models incorporate a constitutive description of the
material separation process during failure. The relevant constitutive description of the material
separation process is of a softening type, defined as the relationship between crack surface
tractions and material separation. Under monotonic loading, the material separation processes
are characterized by a critical traction level, the material strength (σ0), which is related to the
load carrying capacity and the density of the mineralized collagen fibrils. The intrinsic length
scale (δ0) is the material separation distance required such that load transfer between crack
faces ceases to exist. This intrinsic length scale is related to the elongation to rupture of the
mineralized collagen fibrils (Yeni and Fyhrie, 2003). The product of material strength (σ0) and
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intrinsic length scale (δ0) is the fracture toughness (ϕ0), i.e. the energy required to create a unit
area of new fracture surface. Energy dissipation as characterized by ϕ0 is then correlated to the
stored elastic energy as characterized by E0, the tissue elastic modulus.
Under cyclic loading, material degradation can occur if the load remains below the monotonic
material strength σ0. The cyclic material separation processes are characterized by an
endurance limit (Δσ0), a critical traction level below which no damage occurs, and a description
of the accumulation of damage leading to progressive degradation of the material strength
(σ0) in case the applied load exceeds the endurance limit.
Non-linear fracture mechanics models necessarily introduce a size dependence of failure
processes. Such size effects arise naturally as a consequence of the intrinsic length scale (δ0)
and the length measure of the bone architecture. Past studies have previously explored aspects
of the size dependence of static failure (Needleman, 1990, Carpinteri, 1991, Gao and Ji,
2003, Bazant 2005, Taylor 2008) and fatigue (Kitagawa and Takahashi, 1976, El Haddad et
al., 1979, Taylor, 1999, Wang and Siegmund, 2006, Pugno and Carpinteri, 2007) as related to
engineering materials and structures. While such studies commonly focus on configurations
dominated by normal stresses, the same type of size effects have also been observed in shear
stress dominated configurations (Bazant and Cao, 1996, Morel and Valentine, 1996) as relevant
in anisotropic beam-structures. Non-linear fracture models of bone have focused on quasistatic
loading of cortical bone (Yeni and Fyhrie, 2003, Ural and Vashishth, 2006, Yang et al.,
2006, Kasiri and Taylor, 2008, Ural, 2009). A non-linear fracture model for simulation of
failure of cancellous bone was employed by Tomar (2009). This study provides insight into
detailed local aspects of trabecular failure based on the detailed analysis of two specific
cancellous microstructures. Using the virtual internal bond model, Fang et al. (2010) studied
trabecular bone microdamage and determined the relavant contribution of plate and rod-like
trabeculae to damage.
Our present study employs a non-linear fracture mechanics model to study failure of trabecular
bone. It specifically addresses the hypothesis that the differences in the changes of mechanical
properties and microdamage accumulation in cancellous bone treated with BP and SERM could
arise as an outcome of size effects, i.e. from synergistic effects between length scales intrinsic
to the bone tissue mechanical properties and length scales characteristic of the bone
architecture. We first review data from an animal model. A subset of the data from the animal
model provides the input for the mechanics model. The engineering mechanics model defines
equations that predict interaction effects between the material characteristic length scale and
the length scales characteristic of the bone architecture. Model predictions are subsequently
compared to experimental findings from the animal model.
2. Methods
2.1 Experimental Methods
Female beagle dogs (1-2 years old) were treated for 1 year with daily oral doses of drugs
commonly used for the treatment of post-menopausal osteoporosis, BP (alendronate, n = 12/
group) and a SERM (raloxifene, n = 12) (Allen et al., 2006). A separate control group of animals
(n = 12) was treated orally with saline for 12 months.
Following sacrifice, areal bone mineral density (aBMD, g/cm2) of the fourth lumbar vertebrae
was measured using a PIXImus II densitometer (Lunar Corp), according to established
protocols previously described (Allen et al., 2006). Static histomorphometric measures of
fractional bone volume (BV / TV, %) and trabecular thickness (Tb / Th, μm) were made on the
second lumbar vertebrae using a semi-automatic analysis system (Bioquant OSTEO 7.20.10,
Bioquant Image Analysis Co.) attached to a microscope (Nikon Optiphot 2). Measurements
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were made in a 5 × 5 mm region of interested, 1 mm below the cranial plateau. Trabecular ash
weight was used to quantify the mineral content.
Separate vertebrae (third lumbar) were stained en bloc for analysis of bone microdamage,
which was assessed microscopically using ultraviolet fluorescence. Measurements included
crack density (Cr.Dn,/mm2) and mean crack length (Cr.Le, μm).
The biomechanical properties of the fourth lumbar vertebrae were measured using a
servohydraulic testing system (MTS 810, MTS Corporation). Compression to failure was
performed on saline-soaked specimens in displacement mode (20 mm/min). Specimen stiffness
S, ultimate load Pmax, and energy to ultimate load UB are obtained. The modulus of the
trabecular bone EB, its ultimate stress σB and energy density to ultimate load are obtained as
EB = [S × (H / CSA)], σB = [Pmax / CSA], and uB = [UB/ (H × CSA)], respectively, where H and
CSA are specimen height and cross-sectional area, respectively, (Turner and Burr, 1993).
Subsequently, corresponding trabecular scale properties (trabecular modulus ET, trabecular
strength σT and modulus of toughness uT) are calculated by employing the fractional bone
volume:
(1a)
(1b)
(1c)
Equation (1) provides commonly used formulas to obtain first order estimates of trabecular
scale properties. The linear relationships between bone level properties and trabecular level
properties with a scaling parameter BV / TV is the simplest assumption and provides upper
bound values only. Recent computational studies on trabecular bone failure (Fang et al.,
2010) confirm an overall linear relationship between trabecular bone yield strength and BV /
TV. As Eq. (1) only predicts overall bone properties it does not account for the details of the
bone architecture and local stress enhancements leading to failure, and is not sensitive to
architectural changes at constant BV / TV.
Collagen content and cross-linking were evaluated from a core removed from the fourth lumbar
vertebrae following mechanical testing. The bone was isolated and powdered in liquid nitrogen,
and then lyophilized. Cross-linking was measured using an HPLC protocol previously
described (Allen et al., 2008). A remaining portion of the lyophilized bone powder was used
to assess native (α) and isomerized (β) forms of C-telopeptide (CTX). The concentration of
α-CTX and β-CTX fragments was measured by sandwich assays, and the ratio α/β CTX, which
is inversely proportional to collagen maturity, was calculated (Allen et al., 2008).
2.2 Mechanics
We aim to determine dependence of the failure behavior of trabeculae on the properties of the
tissue constituting a trabecula and a relevant size parameter characterizing the cancellous bone
architecture.
We first consider monotonic loading. We defined a relationship that correlates the strength of
a trabecula (σT) to the properties of the trabecular bone tissue emerging from properties of
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mineralized collagen fibrils (σ0,δ0,ϕ0 and E0) and size expressed by trabecular thickness
(Tb.Th). Also, a relationship characterizing the brittleness of the subsequent failure on
(σ0,δ0,ϕ0 and E0) and (Tb.Th) is sought. To characterize the dependence of strength on
trabecular thickness it is useful to define size in mechanical terms. A length is introduced by
the combination of parameters characterizing elastic deformation and material separation
(Orowan, 1949). Consider a stress σ carried by a trabecula of dimension Tb.Th. Then, the elastic
strain energy stored is proportional to the volume of the trabecula (σ2/2E0)(Tb.Th)3. A critical
condition is obtained if failure occurs such that the applied stress reaches the material strength,
σ = σ0. The stored energy at this instance is Wel = (σ02 / 2E0)(Tb.Th)3. The energy dissipated
during fracture (Wf), however, would scale with the crack surface area as Wf = ϕ0 (Tb.Th)2.
When considering a failure process such that all elastic strain energy is dissipated during
fracture (Wel = Wf) a characteristic dimension (LS) emerges as the ratio of the product of fracture
toughness (ϕ0) and elastic modulus of the tissue (E0) to the square of the separation strength
(σ0):
(2)
The characteristic dimension (LS) relates to the extension of the zone of active material
degradation. An alternative expression for the characteristic dimension is obtained by
considering that fracture toughness (ϕ0) is proportional to the product of material strength
(σ0) and intrinsic length scale (δ0) as ϕ0 ∼ σ0δ0. Then, with Eq. (2) the characteristic dimension
(LS) is defined as the ratio of the product of intrinsic length scale (δ0) and elastic modulus
(E0) to the separation strength (σ0):
(3)
The definitions of characteristic dimensions of Eqs (2) and (3) have previously been given by
Hillerborg (1984) for concrete and others (Bao and Suo, 1992;Suo et al., 1993;Cox and
Marshall, 1994) for crack bridging composites. In the context of bone mechanics, Eq. 2 was
previously proposed in (Gao et al., 2003) and (Ji and Gao, 2004) to assess the fracture strength
characteristics of mineral platelets. Considering failure of trabecular bone the intrinsic length
scale (δ0), the separation strength (σ0) and the elastic modulus (E0) are related to the
biomechanical response of the mineralized collagen fibrils. How changes in treatment are
thought to affect these parameters is discussed in Section 3.2.2 of this study.
In order to capture the features associated with mechanical failure of a trabecula, size
(Tb.Th) is now expressed relative to the characteristic dimension (LS). The normalized size
ΛS is introduced as ΛS = [(Tb.Th) / LS] (Gao and Chen, 2005). The quantity ΛS also
characterizes the brittleness of the failure process (Carpinteri, 1997, Gao and Chen, 2005).
In a mechanically large trabecula (ΛS > 1, and thus LS < Tb.Th) the elastic strain energy stored
up to the onset of failure dominates over the energy dissipated during failure, Wel > Wf. The
strength of a trabecula (σT) is obtained by comparing Wel and Wf. It is dependent on inverse of
the normalized size ΛS and is proportional to material separation strength (σ0):
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(4)
Consequently, an increase in normalized size leads to decrease in the strength of a trabecula.
As Λs > 1, failure is driven by an exceeding availability of stored strain energy. Consequently,
the post-peak load behavior is unstable and appears as brittle with a rapid drop in load or even
a snap-back response past the ultimate load. For mechanically large trabeculae, the domain of
active material degradation is small compared to the structure. This zone is confined to the
crack tip and surrounded by an elastic domain. The magnitude of the stresses responsible for
crack opening scales as , where (r) is the distance from the crack tip. Such a stress field
possesses high stresses at the crack tip, and low stresses remote from the crack tip.
The increase in the strength of trabeculae (σT) with decreasing size, Eq. (4), is limited by the
material separation strength (σ0). For trabeculae with ΛS<1 the strength is:
(5)
In such mechanically small trabeculae (ΛS<1, and thus LS > Tb.Th) the energy dissipated during
fracture dominates over the elastic strain energy stored up to the onset of failure, Wel < Wf. The
failure process is no longer driven by the stored elastic energy, and can occur only if energy is
provided continuously through the external load. As a consequence, the post-peak load
behavior of mechanically small trabeculae is ductile, with only a gradual drop in load past the
ultimate load. In mechanically small trabeculae, the zone of active material degradation is large
and of the order of (Tb.Th). Stress fields associated with defects in such mechanically small
trabeculae are distributed uniformly throughout, and the stress concentration at the crack tip
vanishes.
In fatigue, a cyclically varying applied stress is considered and the amplitude Δσ of the applied
stress characterizes the load. The fatigue limit of a trabecula ΔσT defines a load level Δσ below
which no initiation of damage will occur in the trabecula. We aim to establish a relationship
that relates ΔσT to parameters characterizing the mechanical properties of the tissue
(Δσ0,δ0,ϕ0 and E0) and the architecture (Tb.Th). Also, a characterizing of the subsequent crack
growth processes in dependence of (Δσ0,δ0,ϕ0 and E0) and (Tb.Th) is sought. If the load
amplitude Δσ exceeds the endurance limit ΔσT then failure is possible. Cyclic failure response
can be quantified by the number of cycles to initiation of crack growth (Nini) and the number
of total load cycles to failure (Nf).
A generalized description of the size dependence of the fatigue limit is obtained if in the
considerations leading to Eqs. (3)-(5) material separation strength σ0 is substituted with the
endurance limit Δσ0. Following Eq. (3), the characteristic dimension for fatigue failure, LF,
emerges as:
(6)
The ratio between endurance limit and strength is α = Δσ0 / σ0. A second normalized size
parameter ΛF is introduced as ΛF = (Tb.Th) / LF. The ratio α = Δσ0 / σ0 is less than one, and
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consequently ΛF > ΛS. Trabeculae appear as mechanically large in fatigue loading if ΛF >1,
or LF < Tb.Th. Then, the fatigue strength of a trabecula ΔσT depends on its size:
(7)
For mechanically large trabeculae, ΛF > 1, stresses are concentrated at the crack tip, and
material degradation under cyclic loading is also localized at the crack tip. Rapid accumulation
of damage thus occurs locally at the crack tip and initiation of a defect occurs readily such that
the number of load cycles to defect initiation (Nini) is small. Subsequently, a confined zone of
material degradation moves through the structure and leaves free crack surfaces in its wake,
i.e. the crack extends via a mechanism of crack propagation. Such a process is characterized
by a crack advance (Δa) per load cycle (N), and the crack growth rate (Δa / N) is finite. Fatigue
failure of a mechanically large trabecula is consequently dominated by the crack propagation
stage, and the number of load cycles to initiate crack growth (Nini) is only a small fraction of
the total number of cycles to failure (Nf).
The increase in the trabecular fatigue strength (ΔσT) with decreasing size, Eq. (7), is limited
by the material endurance limit (Δσ0). For trabeculae with ΛF<1 the fatigue strength of the
trabecula is thus:
(8)
For mechanically small trabeculae, ΛF<1, the change in the characteristics of the stress
distribution also changes the response to fatigue loading. Spreading stresses over a larger area
reduces the maximum value of the stresses. As a result of the lower stress level, the rate of
damage accumulation is lower than the rate of damage accumulation locally at the crack tip in
mechanically large trabeculae. The onset of fatigue failure in a mechanically small trabecula
is consequently delayed relative to that of a mechanically large trabecula, and the number of
cycles to crack growth initiation (Nini) is increased. On the other hand, accumulation of fatigue
damage occurs more homogeneously throughout the entire trabecula. Consequently, for ΛF<1
the rate of crack extension (Δa / N) is high, or even instantaneous following initiation.
3. Results
3.1 Experimental Data and Model Input
BP treatment increased the fractional bone volume (BV / TV) by 20% relative to the control
group (Veh, p < 0.05). For SERM treatment the increase in the fractional bone volume BV /
TV was small (3%) and not statistically significant. Changes to Tb.Th can be assessed indirectly
through calculation from BV / TV. For the open-cell cellular architectures of trabecular bone
the fractional bone volume relates to Tb.Th as BT / TV = const(Tb.Th)2 (Gibson and Ashby,
1997). This approach indicates an increase in Tb.Th relative to Veh of 9% for BP treatment,
but only 1.5% for SERM treatment. Measurements found an increase in Tb.Th relative to Veh
of 12% for BP, and 8% for SERM. Both changes were found to be below statistical significance.
Changes in BV / TV are also reflected in bone mineral density data. For BP bone mineral density
(BMD) increases ∼10%- (p < 0.05). SERM treatment did not significantly alter BMD. Data on
trabecular bone architecture and density are summarized in Table 1. The effects of SERM and
BP treatments also were found to differ in their influence on collagen cross-linking. BP
treatment was associated with statistically significant increases in collagen cross-linking – both
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affecting collagen cross-links formed in the presence of enzymes (pyridinoline and
deoxypyridinoline) and those that are non-enzymatically formed (e.g., pentosidine). SERM
treatment had no statistically significant effect on either pentosidine concentration [PEN] or
the ratio of non-enzymatic cross-link concentrations[PYD]/[DPD]. Collagen maturity,
inversely related to isomerization expressed as the ratio of α / β C-telopetides, (α / β CTX),
also increased significantly with BP-treatment and was unchanged with SERM treatment
(Table 2).
3.2 Model Predictions
3.2.1. Parametric Model Study—Figure 1 depicts the model predictions of normalized
trabecular strength (σT/ σ0), Eqs (4-5) and fatigue strength (ΔσT/ Δσ0), Eqs (7-8), in dependence
of the normalized size. The choice α = (1 / 3) was made without loss of generality. The size
axes ΛS, ΛF are thus not identical, and the axis of ΛF is shifted to the right relative to ΛF. A
parametric study of changes to strength of trabeculae, σT and ΔσT, with changes in size ΛS,
ΛF is provided first such that basic cases of property alteration due to size effects are outlined.
Each trabecula possesses a value of ΛS, and for a trabecular bone specimen a range of ΛS can
be defined. Still, an order of magnitude estimate for ΛS needs to be obtained. Micrographs of
loaded trabecular bone samples indicate that delamination cracks with a crack opening of the
order of 10 μm remain fully bridged (Thurner et al., 2006,Thurner et al, 2007). If one considers
a lower bound value for the ratio between the modulus and strength of E0 / σ0=10, then a value
of LS on the order of 100 μm emerges such that – considering data for Tb.Th in Table 1 - an
assumption for the mean value of ΛS ≈ 1 appears reasonable. For a reference case values of
0.1 < ΛS < 10.0 are considered such that the range encompasses both mechanically small and
large trabeculae. The reference case is denoted as Ref With α = 1/ 3 the parameter choice leads
to 0.03 < ΛF < 3.33.
It can be envisioned that changes in size occur without changes to underlying material strength
parameters σ0 and Δσ0. For one case (C1) an increase of ΛS by a factor 1.5 is considered while
a second case (C2) decreases ΛS by that same factor. For case C1 the range of normalized size
changes to 0.15 < ΛS < 15. The weakest trabecula is predicted to possess a normalized strength
of σT / σ0 =0.26 (-18% to Ref for which σT / σ0 =0.32). Also, the increase in size increases the
sub-set of the size range of ΛS in the domain ΛS >1. This not only decreases the mean value
of σT / σ0 but also increases the overall brittleness. In case C2, the range of size is 0.0667 <
ΛS < 6.67, with the weakest trabecula now predicted to possess strength of σT / σ0 =0.39 (+22%
to Ref). Decreasing size increases the sub-set of the size range of ΛS in the domain ΛS <1. The
shift of trabeculae into the domain ΛS <1 increases the mean value of σT/ σ0 and also decreases
the brittleness.
For the evaluation of fatigue strength for case C1, the range of normalized size is 0.05 < ΛF <
5.0. The trabecula with the lowest fatigue limit possesses ΔσT/ Δσ0 =0.15 (-18% to Ref for
which ΔσT/ Δσ0 =0.18). The increase in size increases the sub-set of the size range of ΛF in
the domain ΛF>1. This reduces the likelihood that trabeculae would exhibit high resistance to
initiation of fatigue damage, and the failure processes under cyclic loading becomes controlled
by crack propagation processes following defect formation. For such a situation the crack
density Cr.Dn would be higher than for the reference case, but the crack length Cr.Le of the
individual cracks would be reduced. In case C2 the range of normalized size changes to 0.02
< ΛF < 2.2. The trabecula with the lowest fatigue limit possesses ΔσT / Δσ0 =0.22 (+22% to
Ref). The decrease in size increases the sub-set of the size range of ΛF in the domain ΛF<1.
This increases the likelihood that trabeculae would exhibit high resistance to initiation of
fatigue damage, and the failure processes under cyclic loading becomes controlled by crack
initiation and less by crack propagation. Now, the crack density Cr.Dn would be lower than
for the reference case, but the crack length Cr.Le of the individual cracks would be increased.
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A second possibility is for the normalized size to change due to changes in σ0 and Δσ0. It is
considered that one case (C3) increases ΛS by a factor 1.5 while the other (C4) decreases ΛS
by a factor of 1.5, now through corresponding changes in σ0. Changes to Δσ0 follow from
Δσ0 / σ0 = α. Case C3 (modified size range 0.15 < ΛS < 15) then leads to a range of strength
values between σT / σ0,Ref =1.5 (+50% to Ref) and σT / σ0,Ref =0.39 (+22% to Ref). σ0,Ref
denotes the value of σ0 for the scenario without treatment. While strength clearly increases,
the increase in size again increases the sub-set of the size range of ΛS in the domain ΛS>1, and
thus leads to an increase the overall brittleness. Case C4 (0.667 <ΛS< 6.67), leads to a decreased
strength which is predicted to be between σT / σ0,Ref =0.5 (-50% to Ref) and σT / σ0,Ref =0.19
(-38% to Ref). While strength decreases, the decrease in size increases the sub-set of the size
range for which ΛS<1, and thus leads to decreasing brittleness.
Case C3 (0.05 < ΛF < 5.0) leads to a range of fatigue strength values between ΔσT / Δσ0,Ref
=0.50 (+50% to Ref) and ΔσT / Δσ0,Ref =0.22 (+22% to Ref). Δσ0,Ref denotes the value of
Δσ0 for the scenario without treatment. Despite the increase in fatigue strength, case C3 leads
to a scenario in which the failure processes under cyclic loading becomes controlled by crack
propagation processes following defect formation. Compared to the reference case, the crack
density Cr.Dn would be increased while the crack length Cr.Le of the individual cracks would
be reduced. Case C4 (0.02 < ΛF < 2.2), leads to a decreased fatigue which is predicted to be
in the range of ΔσT / Δσ0,Ref =0.17 (-50% to Ref) and ΔσT / Δσ0,Ref =0.11 (-38% to Ref). The
decrease in size increases the sub-set of the size range for which Λs<1. Thus, case C4 leads to
a scenario in which the failure processes under cyclic loading becomes controlled by crack
initiation rather than crack propagation. In such a case the crack density Cr.Dn would be lower
than for the reference case, but the crack length Cr.Le would be increased.
3.2.2 BP and SERM Treatment—Changes in collagen cross-link density and maturity
determine the mechanical behavior of the mineralized collagen fibril. To date, mechanical
properties of the mineralized collagen fibril have mainly been investigated by use of
mechanics-based models. Of particular relevance are models that capture the shear mode of
deformation in the collagen introduced by the staggered arrangement of the mineral phase
(Jäger and Fratzl, 2000, Gao et al., 2003, Kotha and Guzelsu, 2003, Buehler, 2007, Ji, 2008,
Siegmund et al., 2008). Following these studies, the shear mode of deformation in the collagen
leads to a significant non-linear load-elongation response of the mineralized collagen fibril.
The shear mode of deformation shields the mineral phase from high stresses (Gupta et al.,
2006). Therefore, the deformation response appears as ductile with a non-linear relationship
between load and deformation and a large strain to failure. Collagen cross-linking was shown
to reduce the shear mode of deformation and enhance a stretching mode of deformation both
in the mineralized collagen fibril (Siegmund et al., 2008) as well as in demineralized collagen
fibrils (Buehler, 2008). As a consequence, the relationship between load and deformation
becomes increasingly linear with increasing collagen cross-linking. As the shielding of the
mineral from load is reduced, the fibril also becomes less ductile. Beyond a critical level of
cross-link density the load-deformation response then becomes linear and the fibril appears
brittle. Low cross-link densities are associated with an increase in strength, but again beyond
a critical cross-link density strength remains constant.
Figure 2 schematically depicts the deduced stress-strain response for mineralized collagen
fibrils and compares Veh, BP and SERM conditions. Increased non-enzymatic cross-linking
and increased collagen maturity as found with BP treatment (Table 2) can thus be linked to an
increase in E0 but would little alter σ0. Following the reduction of non-linearity of the
mechanical response with increasing cross-linking, a proportionally larger change (decrease)
in δ0 than in E0 would occur. Considering that for BP treatment the trabecular thickness
Tb.Th increases, this combination of changes results in an increase of the normalized sizes
ΛS and ΛF. Such a scenario would conform to case C1 as outlined in the previous section. The
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present model thus predicts that for BP treatment the following trabecular material property
changes relative to Veh would occur:
1. A reduction in strength of trabeculae σT;
2. An increase in brittleness of trabeculae and a reduced uT;
3. A lowered resistance to micro-defect formation and thus increased crack density
Cr.Dn, and
4. An increase in resistance to micro-defect extension and thus shorter length per crack
Cr.Le;
5. An increase in the stiffness of trabeculae (ET) as the direct consequence of the increase
of the stiffness of mineralized collagen fibrils (E0).
Changes in the properties of trabeculae relate to properties of trabecular bone via Eq. (1). The
present model together with Eq. (1) predicts that for BP treatment only a significant increase
in BV / TV would compensate for the decreases in material properties and lead to the bone
structural property changes relative to Veh:
1. An increase in mechanical strength of trabecular bone σB if the increase in BV / TV is
large than the decrease in σT;
2. An increase in energy density to ultimate load uB if the increase in BV / TV is larger
than the decrease in uT;
3. In addition, a significant increase in trabecular bone modulus EB would occur
consequent to increases in both ET and BV / TV.
For SERM treatment the reduction in collagen maturity (Table 2) can be expected to lead to a
small decrease in strength σ0 and modulus E0. Relevant changes to the stress strain response
are schematically depicted in Fig. 2. The increase of non-linearity of the mechanical response
results in a proportionally larger change (increase) in δ0 than for σ0 or E0. Considering that
SERM treatment only changes Tb.Th slightly, the normalized sizes ΛS and ΛF would tend to
decrease. The behavior following SERM treatment would thus correspond to a combination
of cases C2 and C4. However, as the changes to σ0 are minor case C2 might very well dominate.
This would result in an increased strength of trabeculae σT, decreased brittleness of trabeculae
as measured by ΛS, and increased resistance to micro-defect formation. The present model thus
predicts that for SERM treatment the following trabecular material property changes relative
to Veh would occur:
1. An increase in strength of trabeculae σT;
2. A decrease in brittleness of trabeculae and an increased uT;
3. An increase in resistance to micro-defect formation and thus decreased crack density
Cr.Dn, but
4. A decrease in resistance to micro-defect extension and thus longer length per crack
Cr.Le;
5. A decrease in the stiffness of trabeculae (ET) as the direct consequence of the decrease
of the stiffness of mineralized collagen fibrils (E0).
For SERM treatment, the present model together with Eq. (1) predicts that the following bone
structural property changes relative to Veh would occur because of material property changes
in the absence of a significant change in BV / TV:
1. An increase in strength of trabecular bone σB as σT increases;
2. An increased uB as uT increases;
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3. A decrease in EB following a decrease in ET.
These model predictions are currently based on indirect evidence of changes to σ0, δ0, and
E0, thus predictions are provided as expected trends for trabecular properties and trabecular
bone properties. Table 3 and 4 summarize the model trends.
3.3 Experimental Validation
In the animal model, both BP and SERM treatment lead to increase in trabecular bone modulus
EB and trabecular bone strength σB. However, only SERM treatment was found to increase the
energy density to ultimate load uB. The trabecular level properties present a different picture.
For both BP and SERM treatment the modulus ET increased. However, for BP treatment both
σT and uT decrease, while the values for these parameters increase for SERM treatment. Table
3 summarizes these findings and compares these to model predictions.
The in vivo accumulation of microdamage is documented in measurements of crack density
(Cr.Dn) (number of cracks per area) and average crack length (Cr.Le). Treatment with BP or
with SERM led to different outcomes. For BP, the crack density (Cr.Dn) was significantly
higher than for vehicle. For SERM, however, crack density (Cr.Dn) was only slightly larger
than for vehicle. On the other hand, with SERM treatment the average crack lengths (Cr.Le)
were found to be significantly larger than in vehicle while for BPs crack lengths (Cr.Le) were
found only to be slightly increased relative to vehicle. Table 4 summarizes these results and
compares these to model predictions.
4. Discussion
4.1 Mechanics of Size Effects
The present study proposes the application of deterministic and energetic size effects in fracture
and fatigue to the study of bone failure. Such has been applied to investigations of engineering
materials as well as certain biological materials. Alternative to the energetic approach followed
here, it has recently been proposed that such size effects could also be studies based on fractal
approaches (Carpinteri, 1994). While ongoing debate on the merits of the two approaches
exists, the theory of the energetic size effect was chosen for the present study. Probabilistic
approaches to fracture and fatigue also can play a role in the studies of size effects (Taylor,
2000). Then, a combined energetic-probabilistic framework could provide enhanced
capabilities (Bazant, 2005). The equations describing the size effect, Eqs. (4-5), constitute only
a basic framework of the approach. More advanced descriptions would also introduce a
transition regime between the mechanical large and mechanically small domains such that a
domain with a mixed large-small response would exist. In view of the clarity of arguments and
the difficulties in identifying further material parameters for such more advanced models, Eqs.
(4-5) were chosen to provide a basic framework of the proposed novel approach to fracture of
cancellous bone. The extension of Eqs. (4-5) to fatigue failure was theoretically proposed in
Wang and Siegmund (2006). Several features of that model are found in bone in general. A
size effect on fatigue as defined by Eqs. (7-8) was experimentally shown to exist for dentin
(Kruzic and Ritchie, 2006) where size was expressed as initial crack length. Nevertheless,
fatigue failure mechanisms in trabecular bone warrant further investigation.
4.2 From Bone Matrix Constituents to Bone Properties
Mineralized collagen fibrils form the material underlying bone. Trabeculae are small bone
tissue elements in the form of plates or rods, which are composed of this protein-based material.
In a trabecula the mineralized collagen fibrils are strongly aligned along the long-axis of the
bone tissue element. An assembly of a number of trabeculae finally forms the trabecular
architecture. Compression failure of trabecular bone has been linked to the formation of shear
Siegmund et al. Page 11
J Theor Biol. Author manuscript; available in PMC 2011 July 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
damage zones within trabeculae (Fyhrie et al., 1994, Wenzel et al., 1996) and delaminations
(Thurner et al., 2006, Thurner et al, 2007), which are aligned with the long axis of the individual
trabecula. Delaminations have been documented to be bridged by mineralized collagen fibrils,
fibril bundles and non-fibrillar organic substances (Thurner et al, 2007). Stretching and rupture
of mineralized collagen fibrils thus constitute the major portion of the processes determining
trabecular bone failure. The formation of such delaminations and their propagation can be
studied using fracture mechanics. High resolution images of permanently deformed trabecular
bone (Thurner et al, 2007) indicate that the spatial extension of the material degradation zone
can be as large as the trabecular thickness, and is thus significant in relation to the structural
dimension of a trabecular strut. These findings suggest that methods of non-linear fracture
mechanics are necessary to understand the failure process of interest. It is appropriate to
characterize trabeculae as elastic solids in which a finite zone of active material degradation
is embedded. The zone of active material degradation is the domain in which stretching and
rupture of mineralized collagen fibrils take place. While an exact connection between
modification of collagen cross-linking and maturity to the mechanical properties of the
mineralized collagen fibril is still missing, the qualitative trends of the dependence of the
mechanical properties of the mineralized collagen fibril on collagen cross-linking can be
established.
Size effects on trabecular-level strength can be clearly assessed if the geometric dimensions
are uniquely measureable, and if material properties can be assessed experimentally. Such
favorable conditions are not present in trabecular bone where spatial variations in
microarchitecture and in material properties introduce additional variability into the analysis.
Furthermore, direct measurements of material properties might not be possible. We can thus
not a-priori determine if a particular bone is to be classified as mechanically large or small.
Nevertheless, several trends on bone failure can still be inferred.
4.3 BP Treatment
For conditions of BP treatment, the processes of increasing (Tb.Th) and the changes associated
with decreasing characteristic dimension (LS) individually and in combination predict a
tendency towards an increase in the normalized size ΛS. Starting from the untreated condition
an increase in (Tb.Th) alone would lead to an increase in mechanical size for trabeculae for
which (Tb.Th) is larger than (LS) of the untreated state. For such trabeculae the strength (σT)
would decrease. Furthermore, as (Tb.Th) is increased it is likely that a number of trabeculae
will move from the mechanically small to the mechanically large regime, such that the number
of trabeculae in the mechanically large regime would increase. Such trabeculae thus no longer
possess the maximum possible strength σT = σ0 and would tend to possess enhanced brittleness.
Similarly, the decreasing characteristic dimension (LS) would equally contribute to a decrease
in trabecular strength and increase in brittleness even if considered as an independent process.
During BP treatment the increase in (Tb.Th) and the decrease in characteristic length (LS) are
concurrent processes which reinforce each other, resulting in an even stronger trend of reduced
trabecular-level strength (σT) and brittleness. For BP conditions both quantities, (σT) and
(BV /TV), change. Although we argue that BP-treatment would decrease trabecular level
strength (σT), the increase in (BV / TV) - in line with (BMD) increase - can compensate for the
loss in trabecular-level strength such that overall bone strength σB will increase. The increase
in bone strength found for BP conditions is thus attributed to the increase in the fractional
trabecular bone volume BV / TV which compensates for the reduced trabecular-level strength
σT (Allen et al., 2006). Results from experimental studies on animal models under BP treatment
conditions are quite well aligned with the model predictions. As BP-treated conditions overall
tend to increase mechanical size, the expected post-peak behavior during failure of a trabecula
will tend to be rather brittle and allow for little or no energy absorption past the peak load. The
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experimental study of (Allen et al., 2007) indicates that the trabecular-level modulus of
toughness (uT) of BP treated dog bone was indeed lower relative to untreated conditions.
For mechanically large trabeculae - a condition for which (LC) is small and (Tb.Th) tends to
be large relative to (LC) - the initiation of crack growth from an existing defect is easier, and
(Nini) lower. However, further crack growth would occur slowly. As such, the level of stresses
in the structure remains at a high level for a longer period of time, and the formation of
additional cracks would remain a possibility. Such a scenario conforms to findings for BP
conditions – i.e. where trabeculae would behave as mechanically large – such that the crack
density (Cr.Dn) is high but crack lengths (Cr.Le) are low (Allen et al., 2006). These predictions
coincide completely with experimental observations (Table 4).
4.4 SERM Treatment
For SERM-treated bone, a different scenario emerges. Now, only an increase the characteristic
dimension (LS) is of concern because (Tb.Th) does not change. Again, starting from the
untreated condition, an increase in (LS) would lead to a decrease in the normalized size ΛS.
Furthermore, as (LS) increases more trabeculae will be in the range ΛS<1 and now fall into the
mechanically small regime. As SERM-treated conditions overall tend to decrease mechanical
size, the expected post-peak behavior during failure of a trabecula will tend to be rather more
ductile, as well as lead to an increase in trabecular-level strength. For SERM conditions BV /
TV remains rather constant, and any increase in bone strength found for SERM conditions is
thus attributed to the increase in trabecular-level strength σT only. Experimental studies (Allen
et al., 2006, Allen et al., 2007) indeed found an 11% increase in trabecular-level strength for
SERM treatment. The experimental study of (Allen et al., 2006, Allen et al., 2007) also indicates
that the trabecular-level modulus of toughness of SERM treated dog bone was enhanced
relative to untreated conditions, as expected for a more ductile material that allows for energy
absorption past the peak load (Table 3).
Mechanically small or mechanically large trabeculae also will respond differently to cyclic
fatigue loading. In mechanically small trabeculae - a condition for which (LC) is large and
(Tb.Th) tends to be small relative to (LC) - the initiation of crack growth from an existing defect
would be delayed. However, if a crack was initiated, that crack would tend to advance rapidly
to greater length. The growth of this crack increases the compliance of the structure leading to
a reduction in the overall stress level. This reduction in stress would prevent the formation of
further microcracks in that trabecula. Such a scenario aligns with the finding that in SERM
conditions – i.e. in a condition tending towards trabeculae behaving as mechanically small -
the crack density (Cr.Dn) is low but crack lengths (Cr.Le) are large (Allen et al., 2006).
5. Conclusion
The model predictions are based on the assumption of a unique value of trabecular width in a
given bone specimen. In a given bone the magnitude of trabecular width is certainly not
constant. A scenario can be envisioned where the thinnest trabeculae would be mechanically
small structures while the thicker trabeculae would be mechanically large structures. It can
then be argued that BPs are effective in such a scenario because they increase the load carrying
capability of the weakest link in the bone overall while SERMs would not provide such an
effect. However, this mechanism in BPs would only be effective as long as the thinnest
trabeculae can be considered as mechanically small structures, and points towards the potential
existence of a critical trabecular width beyond which a treatment with BPs would be effective
while SERMs would not affect bone load carrying capability. As a possible consequence the
potential emerges that BPs would be more effective in those cases in which BMD is extremely
low, whereas SERMs may be more effective when milder osteoporotic symptoms are present.
To obtain quantitatively predictive results with the method proposed here, experiments on
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failure and fatigue of individual trabeculae need to be conducted and such information be
merged with an analysis of size, defect and load distribution within the assembly of trabeculae
in the cancellous bone overall.
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Figure 1.
Predicted dependence of the normalized strength of trabeculae (σT / σ0) and normalized fatigue
strength of trabeculae (ΔσT / Δσ0) on normalized size ΛS, ΛF.
Siegmund et al. Page 17
J Theor Biol. Author manuscript; available in PMC 2011 July 21.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Schematic drawing of expected characteristics of mineralized collagen fibrils for Veh, BP and
SERM treatment.
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Table 1
Fractional bone volume, BV / TV, trabecular thickness Tb.Th (direct measure and calculated values from BV /
TV), and bone mineral density BMD for Veh, BP and SERM treatment. Statistically significant difference relative
to Veh following BP treatment indicated by a. Following Allen et al. (2006).
BV / TV, % Tb.Th, μm BMD, g/cm2
Direct measure Calculated
VEH 21.9 ± 0.9 69.4±2.8 69.4 0.33 ± 0.01
BP 26.4 ± 1.0a 77.9±4.0 75.6 0.36 ± 0.01a
SERM 22.6 ± 1.0 75.2±3.6 70.4 0.31 ± 0.01
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Table 2
Collagen cross linking and collagen maturity for Veh, BP and SERM treatment. [PYD]/[DPD], ratio of
pyridinoline and deoxypyridinoline concentration; [PEN] pentosidine concentration; α/β CTX collagen maturity.
Statistically significant difference relative to Veh following BP treatment indicated by a, relative to Veh following
SERM treatment indicated by b. Following Allen et al. (2008).
[PYD]/[DPD] [PEN], mmol / mol collagen α/β CTX
VEH 4.63 ± 0.24 1.24 ± 0.08 0.412 ± 0.043
BP 5.45 ± 0.20a 1.69 ± 0.04a 0.252 ± 0.031a
SERM 4.75 ± 0.17 1.27 ± 0.08 0.432 ± 0.025b
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Table 4
Microdamage accumulation for Veh, BP and SERM treatment. Mean crack length, Cr.Le, and crack density Cr
.Dn. Statistically significant difference relative to Veh following BP or SERM treatment indicated by a.
Statistically significant difference relative to SERM treatment b. Statistically significant difference relative to
BP treatment c. Experimental data Following Allen et al. (2006). Comparison to trends predicted by the present
model.
Cr.Dn, #/mm2 Cr.Le, μm
VEH 0.130 ± 0.04 51.8 ± 4.5
BP
 Experiment Model trend 0.450 ± 0.08 ab ↑ 56.5 ± 3.4 ↓
SERM
 Experiment Model trend 0.189 ± 0.05 ↓ 76.6 ± 3.0 ac ↑
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